Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis, and retrospective study
Abstract: Antiangiogenic agents, including vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs), represent an important class of treatments for a range of solid tumors. However, concerns have arisen over potential associations between antiangiogenic agents and thromb...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2026-01-01
|
| Saila: | Blood Advances |
| Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S2473952925006238 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|